The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients

  COVID-19 disease is a clinical syndrome caused by an envelope RNA virus, called SARS-COV-2., which causes infection with wildly clinical pictures. Through COVID-19 infection several components of humoral and cellular immune response have an important role in the progression of the infection. Chem...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra'a Abdul AL-Aziz Yousif, Jabbar S. Hassan, Ghaith H. Hameed
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2025-02-01
Series:Iraqi Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3815
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850067145892823040
author Zahra'a Abdul AL-Aziz Yousif
Jabbar S. Hassan
Ghaith H. Hameed
author_facet Zahra'a Abdul AL-Aziz Yousif
Jabbar S. Hassan
Ghaith H. Hameed
author_sort Zahra'a Abdul AL-Aziz Yousif
collection DOAJ
description   COVID-19 disease is a clinical syndrome caused by an envelope RNA virus, called SARS-COV-2., which causes infection with wildly clinical pictures. Through COVID-19 infection several components of humoral and cellular immune response have an important role in the progression of the infection. Chemokines are one of the inflammatory mediators that play an essential role in the immune pathogenesis of COVID-19. It is secreted by respiratory virus-infected cells in the upper respiratory tract, causing stimulation and recruitment of inflammatory cells such as neutrophils, NK, eosinophils, and macrophages from the bloodstream to the site of the infection. This study strives to determine the impact role of inflammatory mediator chemokine RANTES (CCL5) in COVID-19 Iraq patients. Blood samples collected from 180 individuals were enrolled in this study, 120 of them were patients infected with COVID-19 and verified by reverse transcriptase polymerase chain reaction (RT-PCR). The patients were categorized into two groups based on the severity of the disease, the severe group included 60 patients and the mild/moderate group included 60 patients also. Furthermore, 60 healthy individuals who were confirmed to be COVID-19-negative were enrolled in this study as a control group. The quantitative detection of CCL5 in human serum was done by the CCL5 Enzyme Linked Immune Sorbent Assay kit based on the principle of sandwich ELISA. This study showed that there were interesting highly significant differences (p<0.001) in the median serum level of CCL5 between all groups that participated in this study and there was a significant increase in the median level of CCL5 in control and mild-moderate groups versus severe patients’ group (66.66 pg/ml, and 54.04 pg/ml vs. 38.41 pg/ml respectively). According to the results of this study, the low level of CCL5 associated with COVID-19 severity infection could be used as a predictor marker for severity while the elevated level of CCL5 in control and mild-moderate suggested the elevated level of this chemokine is likely to be associated with the resolution of inflammation and recovery.
format Article
id doaj-art-2dbd06c2ca0d4fb9b5a1606ed0ab2861
institution DOAJ
issn 1683-3597
2521-3512
language English
publishDate 2025-02-01
publisher College of Pharmacy University of Baghdad
record_format Article
series Iraqi Journal of Pharmaceutical Sciences
spelling doaj-art-2dbd06c2ca0d4fb9b5a1606ed0ab28612025-08-20T02:48:28ZengCollege of Pharmacy University of BaghdadIraqi Journal of Pharmaceutical Sciences1683-35972521-35122025-02-0133(4SI)10.31351/vol33iss(4SI)pp304-311The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province PatientsZahra'a Abdul AL-Aziz Yousif 0Jabbar S. Hassan1Ghaith H. Hameed2Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq. Department of Microbiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.Ministry of Health ,MRCP Respiratory Medicine, Imamein Kadhimein, Medical City Baghdad, Iraq.   COVID-19 disease is a clinical syndrome caused by an envelope RNA virus, called SARS-COV-2., which causes infection with wildly clinical pictures. Through COVID-19 infection several components of humoral and cellular immune response have an important role in the progression of the infection. Chemokines are one of the inflammatory mediators that play an essential role in the immune pathogenesis of COVID-19. It is secreted by respiratory virus-infected cells in the upper respiratory tract, causing stimulation and recruitment of inflammatory cells such as neutrophils, NK, eosinophils, and macrophages from the bloodstream to the site of the infection. This study strives to determine the impact role of inflammatory mediator chemokine RANTES (CCL5) in COVID-19 Iraq patients. Blood samples collected from 180 individuals were enrolled in this study, 120 of them were patients infected with COVID-19 and verified by reverse transcriptase polymerase chain reaction (RT-PCR). The patients were categorized into two groups based on the severity of the disease, the severe group included 60 patients and the mild/moderate group included 60 patients also. Furthermore, 60 healthy individuals who were confirmed to be COVID-19-negative were enrolled in this study as a control group. The quantitative detection of CCL5 in human serum was done by the CCL5 Enzyme Linked Immune Sorbent Assay kit based on the principle of sandwich ELISA. This study showed that there were interesting highly significant differences (p<0.001) in the median serum level of CCL5 between all groups that participated in this study and there was a significant increase in the median level of CCL5 in control and mild-moderate groups versus severe patients’ group (66.66 pg/ml, and 54.04 pg/ml vs. 38.41 pg/ml respectively). According to the results of this study, the low level of CCL5 associated with COVID-19 severity infection could be used as a predictor marker for severity while the elevated level of CCL5 in control and mild-moderate suggested the elevated level of this chemokine is likely to be associated with the resolution of inflammation and recovery. https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3815Keywords: CCL5, Chemokine, COVID-19, RANTES, Sandwich ELISA
spellingShingle Zahra'a Abdul AL-Aziz Yousif
Jabbar S. Hassan
Ghaith H. Hameed
The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
Iraqi Journal of Pharmaceutical Sciences
Keywords: CCL5, Chemokine, COVID-19, RANTES, Sandwich ELISA
title The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
title_full The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
title_fullStr The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
title_full_unstemmed The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
title_short The Clinical Role of Inflammatory Chemokine RANTES (CCL5) in a Sample of COVID-19 Baghdad Province Patients
title_sort clinical role of inflammatory chemokine rantes ccl5 in a sample of covid 19 baghdad province patients
topic Keywords: CCL5, Chemokine, COVID-19, RANTES, Sandwich ELISA
url https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3815
work_keys_str_mv AT zahraaabdulalazizyousif theclinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients
AT jabbarshassan theclinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients
AT ghaithhhameed theclinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients
AT zahraaabdulalazizyousif clinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients
AT jabbarshassan clinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients
AT ghaithhhameed clinicalroleofinflammatorychemokinerantesccl5inasampleofcovid19baghdadprovincepatients